Vitiligo
227
21
36
92
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
22 trials with published results (10%)
Research Maturity
92 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.0%
16 terminated out of 227 trials
85.2%
-1.4% vs benchmark
14%
32 trials in Phase 3/4
24%
22 of 92 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 92 completed trials
Clinical Trials (227)
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Study of D-2570 in Subjects With Non-Segmental Vitiligo
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo
Defining the Role of the Skin Microbiome in Immune-related Adverse Events
PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
Excimer Lamp Versus Excimer Laser in Vitiligo Treatment
A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo
Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
The Gut and Skin Microbiome in Vitiligo Disease Progression
The Value of Methotrexate in NCES for Stable Vitiligo
Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo
Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
Efficacy and Safety of Ruxolitinib Cream in Chinese Children Aged 2-11 Years With Non-segmental Vitiligo
Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.
Oral Mini Pulse Dexamethasone in Pediatric Vitiligo